Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lichtman

Showing results (181-190 of 267) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840S M Lichtman, A Hurria, C T Cirrincione, et al.
The Lancet. Healthy Longevity|September 13, 2022
Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situationBen Sprangers, Annelien Van der Veen, Marije E Hamaker, et al.
Leukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.
Age and Ageing|May 1, 1992
Use of cisplatin for elderly patientsS M Lichtman, M Buchholtz, J Marino, et al.
The Journal of Experimental Medicine|April 1, 1995
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cellsS Hashimoto, M Dono, M Wakai, et al.
Leukemia & Lymphoma|March 26, 2002
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150S M Lichtman, G Petroni, R L Schilsky, et al.
Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.
Gynecologic Oncology|December 1, 2009
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatmentRoisin O'Cearbhaill, Qin Zhou, Alexia Iasonos, et al.
Journal of the American Geriatrics Society|April 1, 1996
No increased risk of Taxol toxicity in older patientsS M Lichtman, W Zaheer, D Gal, et al.
Autoimmunity|January 1, 1994
IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewingM Wakai, S Hashimoto, M Omata, et al.
Pageof 27

Showing results (181-190 of 267) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840S M Lichtman, A Hurria, C T Cirrincione, et al.
The Lancet. Healthy Longevity|September 13, 2022
Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situationBen Sprangers, Annelien Van der Veen, Marije E Hamaker, et al.
Leukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.
Age and Ageing|May 1, 1992
Use of cisplatin for elderly patientsS M Lichtman, M Buchholtz, J Marino, et al.
The Journal of Experimental Medicine|April 1, 1995
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cellsS Hashimoto, M Dono, M Wakai, et al.
Leukemia & Lymphoma|March 26, 2002
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150S M Lichtman, G Petroni, R L Schilsky, et al.
Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.
Gynecologic Oncology|December 1, 2009
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatmentRoisin O'Cearbhaill, Qin Zhou, Alexia Iasonos, et al.
Journal of the American Geriatrics Society|April 1, 1996
No increased risk of Taxol toxicity in older patientsS M Lichtman, W Zaheer, D Gal, et al.
Autoimmunity|January 1, 1994
IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewingM Wakai, S Hashimoto, M Omata, et al.
Pageof 27